XML 21 R2.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME / (LOSS) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Total revenue, net $ 379,095 $ 365,854 $ 1,122,430 $ 1,089,126
Costs and expenses:        
Cost of goods sold 142,636 143,245 415,219 425,032
Research and development 19,003 20,309 53,280 57,742
In-process research and development 59,889 0 61,566 0
Selling, general and administrative 173,098 173,355 513,345 513,518
Intangible asset amortization 5,056 5,268 21,340 15,944
Total costs and expenses 399,682 342,177 1,064,750 1,012,236
Operating income (loss) (20,587) 23,677 57,680 76,890
Interest income 2,913 75 8,051 325
Interest expense (13,962) (14,478) (40,495) (50,750)
Other income, net 4,127 1,750 8,461 6,422
Income (loss) before income taxes (27,509) 11,024 33,697 32,887
Provision (benefit) for income taxes 101 (2,271) (1,185) (2,776)
Net income (loss) $ (27,610) $ 13,295 $ 34,882 $ 35,663
Net income (loss) per share        
Basic (in dollars per share) $ (0.32) $ 0.16 $ 0.41 $ 0.43
Diluted (in dollars per share) $ (0.32) $ 0.15 $ 0.40 $ 0.43
Weighted average common shares outstanding (See Note 13):        
Basic (in shares) 85,688 85,193 85,536 82,058
Diluted (in shares) 85,688 86,299 86,581 83,142
Comprehensive income (loss) (See Note 14) $ (46,521) $ 12,330 $ (7,288) $ 33,731